| Theme |
Informed Consent and Preparation on Renal Replacement Therapy for Patients with End Stage Renal Disease |
| Title |
Capacity of CKD patients to make treatment decisions |
| Author |
Hiroyuki Terawaki |
Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine / Research Division of Dialysis and Chronic Kidney Disease, Tohoku University Graduate School of Medicine |
| Author |
Masaaki Nakayama |
Research Division of Dialysis and Chronic Kidney Disease, Tohoku University Graduate School of Medicine |
| [ Summary ] |
Proper informed consent (IC) should be based on sufficient capacity to make treatment decisions. Unfortunately, such capacity may be impaired in patients with advanced stage of chronic kidney disease (CKD) due to uremia. In fact, we were formerly sure that predialysis CKD stage 5 patients' (n=26) ability in terms of competence to consent to treatment was impaired partly due to concentrate. Therefore, when we obtain IC under such conditions, we must take into account the possible impairment of ability to make competent decisions. |